In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Vir Biotechnology Inc (NASDAQ: VIR) closed at $9.10 in the last session, down -3.91% from day before closing price of $9.47. In other words, the price has decreased by -$3.91 from its previous closing price. On the day, 1.2 million shares were traded.
Ratios:
We take a closer look at VIR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.94 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $23 previously.
On September 08, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $14.
JP Morgan Upgraded its Neutral to Overweight on March 06, 2023, whereas the target price for the stock was revised from $35 to $34.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 24 ’25 when SCANGOS GEORGE A sold 10,056 shares for $9.45 per share. The transaction valued at 95,063 led to the insider holds 698,239 shares of the business.
HANLY ANN M. sold 14,168 shares of VIR for $133,936 on Feb 24 ’25. The EVP & Chief Technology Officer now owns 117,901 shares after completing the transaction at $9.45 per share. On Feb 24 ’25, another insider, Sabatini Brent, who serves as the SVP, Chief Accounting Officer of the company, sold 1,562 shares for $9.45 each. As a result, the insider received 14,766 and left with 46,627 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 15.94 while its Price-to-Book (P/B) ratio in mrq is 1.00.
Stock Price History:
Over the past 52 weeks, VIR has reached a high of $14.45, while it has fallen to a 52-week low of $6.56. The 50-Day Moving Average of the stock is -1.01%, while the 200-Day Moving Average is calculated to be 2.27%.
Shares Statistics:
A total of 136.71M shares are outstanding, with a floating share count of 88.07M. Insiders hold about 36.05% of the company’s shares, while institutions hold 51.17% stake in the company.
